Literature DB >> 8508008

Insulin enhances angiotensin II induced DNA synthesis in vascular smooth muscle cells of the rat.

Y Ko1, A Sachinidis, A J Wieczorek, M Appenheimer, R Düsing, H Vetter.   

Abstract

Hypertension has a high prevalence among subjects with decreased insulin sensitivity and/or hyperinsulinemia. Furthermore, angiotensin II plays a pivotal role in the regulation of vascular tone and is known to induce hypertrophy and/or hyperplasia in vascular smooth muscle cells. In the present study, the effect of insulin on angiotensin II induced smooth muscle cell growth (Wistar-Kyoto rat) was investigated. Cell growth was assessed by the measurement of [3H]thymidine incorporation into cell DNA. Insulin in a concentration range of 1.7 x 10(-10)-1.7 x 10(-6) M lacked any effect on cell DNA synthesis. However, insulin enhanced the angiotensin II induced DNA synthesis in a concentration-dependent manner. This effect was similar in cells with a weak and in cells with a marked response in DNA synthesis to stimulation with 100 nM angiotensin II. In conclusion, insulin is able to enhance angiotensin II induced DNA synthesis and may therefore function as a growth cofactor in vascular smooth muscle cells.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8508008     DOI: 10.1007/BF00186627

Source DB:  PubMed          Journal:  Clin Investig        ISSN: 0941-0198


  24 in total

1.  Interaction of receptors for insulin-like growth factor I, platelet-derived growth factor, and fibroblast growth factor in rat aortic cells.

Authors:  B Pfeifle; H Boeder; H Ditschuneit
Journal:  Endocrinology       Date:  1987-06       Impact factor: 4.736

Review 2.  The pathogenesis of atherosclerosis--an update.

Authors:  R Ross
Journal:  N Engl J Med       Date:  1986-02-20       Impact factor: 91.245

3.  Effects of angiotensin II and vasopressin on human smooth muscle cells in vitro.

Authors:  M Campbell-Boswell; A L Robertson
Journal:  Exp Mol Pathol       Date:  1981-10       Impact factor: 3.362

Review 4.  Insulin, insulin sensitivity and hypertension.

Authors:  P Ferrari; P Weidmann
Journal:  J Hypertens       Date:  1990-06       Impact factor: 4.844

5.  Proliferation of smooth muscle cells after vascular injury is inhibited by an antibody against basic fibroblast growth factor.

Authors:  V Lindner; M A Reidy
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-01       Impact factor: 11.205

Review 6.  Endothelium and growth factors in vascular remodeling of hypertension.

Authors:  V J Dzau; G H Gibbons
Journal:  Hypertension       Date:  1991-11       Impact factor: 10.190

Review 7.  Common mechanisms of proliferation of smooth muscle in atherosclerosis and hypertension.

Authors:  S M Schwartz; M A Reidy
Journal:  Hum Pathol       Date:  1987-03       Impact factor: 3.466

8.  Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells.

Authors:  A A Geisterfer; M J Peach; G K Owens
Journal:  Circ Res       Date:  1988-04       Impact factor: 17.367

9.  Effect of insulin on growth of cultured human arterial smooth muscle cells.

Authors:  B Pfeifle; H Ditschuneit
Journal:  Diabetologia       Date:  1981-02       Impact factor: 10.122

Review 10.  Molecular mechanisms of vascular renin-angiotensin system in myointimal hyperplasia.

Authors:  V J Dzau; G H Gibbons; R E Pratt
Journal:  Hypertension       Date:  1991-10       Impact factor: 10.190

View more
  2 in total

1.  Insulin and insulin-like growth factor I differentially induce alpha1-adrenergic receptor subtype expression in rat vascular smooth muscle cells.

Authors:  Z W Hu; X Y Shi; B B Hoffman
Journal:  J Clin Invest       Date:  1996-10-15       Impact factor: 14.808

2.  Heightened efficacy of nitric oxide-based therapies in type II diabetes mellitus and metabolic syndrome.

Authors:  Sadaf S Ahanchi; Vinit N Varu; Nick D Tsihlis; Janet Martinez; Charles G Pearce; Muneera R Kapadia; Qun Jiang; Joseph E Saavedra; Larry K Keefer; Joseph A Hrabie; Melina R Kibbe
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-10-17       Impact factor: 4.733

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.